Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
DOBT.net is a community-based, digital asset trading platform .
A materials technology company.
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.
Advizr creats financial planning software that enables profitable financial planning for all of its customers.
Franklin Templeton has invested in 221 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Franklin Templeton's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Finance. The firm invests across 17 different industry categories.
Among tracked funding rounds, Ionic Materials received $65.0M in a Series C round. Franklin Templeton's total known invested capital is $20.2B.
Franklin Templeton's average investment size is $112.1M across its portfolio of 221 companies.